BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2146395)

  • 1. The role of Escherichia coli haemolysin in the pathogenic synergy of colonic bacteria in subcutaneous abscess formation in mice.
    Ushijima T; Takahashi M; Seto A
    J Med Microbiol; 1990 Sep; 33(1):17-22. PubMed ID: 2146395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent antagonism of Escherichia coli, Bacteroides ovatus, Fusobacterium varium, and Enterococcus faecalis, alone or in combination, for enteropathogens in anaerobic continuous flow cultures.
    Ushijima T; Ozaki Y
    J Med Microbiol; 1986 Sep; 22(2):157-63. PubMed ID: 2875188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between Fusobacterium species and other flora in mixed infection.
    Brook I; Walker RI
    J Med Microbiol; 1986 Mar; 21(2):93-100. PubMed ID: 2936888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The spectrum of Escherichia coli--Bacteroides fragilis pathogenic synergy in an intraabdominal infection model.
    Rotstein OD; Kao J
    Can J Microbiol; 1988 Mar; 34(3):352-7. PubMed ID: 3046726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic effect of bacteroides, Clostridium, Fusobacterium, anaerobic cocci, and aerobic bacteria on mortality and induction of subcutaneous abscesses in mice.
    Brook I; Hunter V; Walker RI
    J Infect Dis; 1984 Jun; 149(6):924-8. PubMed ID: 6429254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. alpha-Haemolysin: an additive virulence factor in Escherichia coli.
    Emödy L; Pál T; Safonova NV; Kuch B; Golutva NK
    Acta Microbiol Acad Sci Hung; 1980; 27(4):333-42. PubMed ID: 7008511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenic synergy between Escherichia coli and Bacteroides fragilis: studies in an experimental mouse model.
    Verweij-van Vught AM; Namavar F; Sparrius M; Vel WA; MacLaren DM
    J Med Microbiol; 1985 Jun; 19(3):325-31. PubMed ID: 3892009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbial synergy in experimental intra-abdominal abscess.
    Onderdonk AB; Bartlett JG; Louie T; Sullivan-Seigler N; Gorbach SL
    Infect Immun; 1976 Jan; 13(1):22-6. PubMed ID: 814099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbiology of liver and spleen abscesses.
    Brook I; Frazier EH
    J Med Microbiol; 1998 Dec; 47(12):1075-80. PubMed ID: 9856643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo efficacy of trovafloxacin against Bacteroides fragilis in mixed infection with either Escherichia coli or a vancomycin-resistant strain of Enterococcus faecium in an established-abscess murine model.
    Stearne LE; Gyssens IC; Goessens WH; Mouton JW; Oyen WJ; van der Meer JW; Verbrugh HA
    Antimicrob Agents Chemother; 2001 May; 45(5):1394-401. PubMed ID: 11302801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reciprocal synergy between Escherichia coli and Bacteroides fragilis in an intra-abdominal infection model.
    Rotstein OD; Kao J; Houston K
    J Med Microbiol; 1989 Aug; 29(4):269-76. PubMed ID: 2668529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Escherichia coli hemoglobin protease autotransporter contributes to synergistic abscess formation and heme-dependent growth of Bacteroides fragilis.
    Otto BR; van Dooren SJ; Dozois CM; Luirink J; Oudega B
    Infect Immun; 2002 Jan; 70(1):5-10. PubMed ID: 11748157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of alpha haemolysin in the virulence of Escherichia coli for mice.
    Linggood MA; Ingram PL
    J Med Microbiol; 1982 Feb; 15(1):23-30. PubMed ID: 6754940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intra-abdominal abscess formation in mice: quantitative studies on bacteria and abscess-potentiating agents.
    Nulsen MF; Finlay-Jones JJ; Skinner JM; McDonald PJ
    Br J Exp Pathol; 1983 Aug; 64(4):345-53. PubMed ID: 6311236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Killing of alpha-haemolytic and non-haemolytic Escherichia coli strains in human serum and polymorphonuclear leucocytes.
    Siegfried L; Puzová H; Kmetová M; Kerestesová A
    J Med Microbiol; 1992 Jul; 37(1):3-7. PubMed ID: 1625312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemolysis by urinary Escherichia coli and virulence in mice.
    van den Bosch JF; Postma P; de Graaff J; MacLaren DM
    J Med Microbiol; 1981 Aug; 14(3):321-31. PubMed ID: 7021838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenicity of Propionibacterium acnes in mixed infections with facultative bacteria.
    Brook I
    J Med Microbiol; 1991 May; 34(5):249-52. PubMed ID: 2030499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An experimental mouse model to study the pathogenicity of Prevotella bivia and investigations of possible virulence.
    Egwari LO; Rotimi VO; Coker AO
    West Indian Med J; 2000 Mar; 49(1):20-6. PubMed ID: 10786446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenicity of capsulate and non-capsulate members of Bacteroides fragilis and B. melaninogenicus groups in mixed infection with Escherichia coli and Streptococcus pyogenes.
    Brook I
    J Med Microbiol; 1988 Nov; 27(3):191-8. PubMed ID: 2903934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of Bacteroides encapsulation in the lethal synergy between Escherichia coli and Bacteroides species studied in a rat fibrin clot peritonitis model.
    Rotstein OD; Pruett TL; Wells CL; Simmons RL
    J Infect; 1987 Sep; 15(2):135-46. PubMed ID: 3312420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.